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ABSTRACT

Disclosed hereinare biodegradable medical devices compris
ing biodegradable materials (e.g., magnesium-calcium
alloys) having an adjustable rate of degradation that can be
used in various applications including, but not limited to, drug
delivery applications, cardiovascular applications, and ortho
pedic applications to make biodegradable and biocompatible
devices. Also disclosed herein are methods of making biode
gradable medical devices comprising biodegradable materi
als by using, for instance, hybrid dry cutting/hydrostatic bur
nishing.
6 Claims, 13 Drawing Sheets
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2
not limited to, implant loosening, damage to the healing pro
cess and adjacent anatomical structures, osteolysis, and
chronic inflammation. To decrease negative effects of stress
shielding, many patients with non-degradable metallic
implants undergo secondary Surgeries to repair, revise, or
remove their implants.
Examples of other medical devices that can be used, for

BODEGRADABLE MEDICAL DEVICE
HAVING ANADJUSTABLE DEGRADATION
RATE AND METHODS OF MAKING THE
SAME
CROSS-REFERENCE TO RELATED
APPLICATIONS

instance, to fixate a bone fracture, include, but are not limited

This application is a nonprovisional application claiming
priority to U.S. Provisional Patent Application No. 61/682,
890, filed Aug. 14, 2012, which is incorporated herein in its
entirety.

10

FIELD OF THE DISCLOSURE
15

The present disclosure relates generally to a biodegradable
medical device made from a biodegradable material having
an adjustable rate of degradation. In particular, the present
disclosure relates to biodegradable medical devices compris
ing biodegradable materials (e.g., magnesium-calcium
alloys) having an adjustable rate of degradation that can be
used in various applications including, but not limited to, drug
delivery applications, cardiovascular applications, and ortho
pedic applications to make biodegradable and biocompatible
devices. The present disclosure also relates to methods of
making biodegradable medical devices comprising biode
gradable materials by using, for instance, hybrid dry cutting/
hydrostatic burnishing.
BACKGROUND

Annually several million people suffer bone fractures
caused by accidents or disease in the United States alone,
resulting in hospitalizations and a notable economic burden
on the U.S. health care system. Moreover, the number of bone
fractures caused by an age-related disease, such as osteoporo
sis, may escalate in industrial nations in the coming years
with increasing life expectancy. Many of those fractures are
too complex for an external medical treatment and must be
Surgically fixed using internal orthopedic medical devices
Such as, for example, implants.
Most orthopedic implants in use are composed of metals.
Current metallic implants are made of for instance, titanium,
stainless steel, and cobalt-chromium alloys that will not
degrade in the human body after implantation because of their
high degradation resistance. Those non-degradable metallic
implants have certain drawbacks, including, but not limited
to, stress shielding and an increased need for secondary Sur
geries.
Stress shielding arises after implanting, for instance, plates
and Screws at the site of a bone fracture. Implants and bone
form a composite structure where the stress becomes dispro
portionally carried. Stiffer components carry larger portions
of the load. The materials used in current metallic implants
are much stiffer (modulus of elasticity ranging from 100-200
gigapascals) than bone tissues (modulus of elasticity ranging
from 10-30 gigapascals). As a result, permanent metallic
implants shield the bone from carrying stress. Since bone is
an efficient living tissue, it adapts itself to new loading con
ditions by remodeling and becoming less dense in stress
shielded areas. This bone remodeling causes pain in patients
with non-degradable metallic implants, especially during the
first few years after implantation. Furthermore, the resultant
decrease in bone density—called artificial osteoporosis by
Some orthopedic Surgeons—is another side effect of stress
shielding that weakens the bone and can lead to refractures.
Other negative side effects of stress shielding include, but are

25

30

to, biodegradable polymer devices, autograft devices,
isograft devices, Xenograft devices, allograft devices, and
ceramic devices. Biodegradable polymer devices have certain
drawbacks, including, but not limited to, their relatively low
mechanical strength and high rate of wear. An implant having
Sufficient mechanical strength can withstand the stress of
load-bearing applications. Allograft, autograft, and isograft
devices are made of human tissue and are biocompatible and
biodegradable. Allograft devices have certain drawbacks
including, but not limited to, their limited Supply. Although
ceramic devices can have a relatively high mechanical
strength, they also have certain drawbacks including, but not
limited to, their brittle and non-biodegradable nature.
Through degradation and wear, cracks can easily initiate and
further propagate until Sudden, catastrophic failure, which
damages Surrounding tissue.
When a bone fractures, the fragments lose their alignment
in the form of displacement or angulation. For the fractured
bone to heal without deformity, the bony fragments must be
realigned to their normal anatomical position. Orthopedic
Surgeons may attempt to recreate the normal anatomy of the
fractured bone by reduction; that is, an orthopedic Surgeon
can use an implant as a device that is placed over or within
bones to hold a fracture reduction.
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The degradation rate of a biodegradable medical device
can impact its performance. If degradation rate of a biode
gradable medical device is faster than healing rate of a bone
fracture, the biodegradable medical device will degrade away
and be absorbed by body before the healing process is over.
This can cause misaligned fragments and ultimately undesir
able deformed bony structure. On the other hand, if the deg
radation rate of the biodegradable medical device is slower
than the healing rate of a bone fracture, the biodegradable
medical device will still be in place long after the healing
process is over. This can cause stress shielding and artificial
osteoporosis. The healing rate of a bone fracture depends on
a variety of factors including, but not limited to, physiological
conditions, age, weight, height, gender, ethnicity, and overall
health, and can differ from one application to the other.
The degradation rates of biodegradable medical devices
can be adjusted to approximate the healing rate of Surround
ing tissues in various applications. For instance, one method
for adjusting the degradation rate of a biodegradable medical
device is by Surface treatment, which can be mechanical or
non-mechanical. One example of a mechanical Surface treat
ment is laser shock peening (LSP). LSP uses pressure waves
formed by plasma expansion to cause plastic deformation of
the implant. Other mechanical surface treatments include, but
are not limited to, cutting, grinding, indenting, shot peening,
micro-forming, and low-plasticity burnishing.
Because some biodegradable materials (for instance, an
alloy of Mg CaO.8) are soft and can easily be indented or
scratched, several mechanical Surface treatments may not be
capable of processing a Surface without causing permanent
damage. For example, shots used in a shot peening technique
could easily penetrate into the surface of those biodegradable
materials, remain on the Surface after the process, and cause
contamination after implantation. Contamination that would
alter the surface biochemistry could result in several short
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term and long-term adverse effects. Machining processes
may also produce Surface contamination that cannot be
removed by normal cleaning. Furthermore, shot peening
requires a relatively high amount of cold work, and produces
relatively low, shallow, and unstable residual stresses.
One example of a non-mechanical method of adjusting the
degradation rate of a medical device includes coating the
biodegradable medical device to reduce the degradation rate.
Coatings may be formed by several processes including, but
not limited to, anodizing, chemical vapor deposition, ion
implantation, physical vapor deposition, conversion coatings,
plating, immersion, and thermal processes. Ensuring the bio
compatibility of a coating material is one drawback. Addi
tionally, coatings may not improve the mechanical strength
and fatigue life through improved surface integrity.
Other methods to adjust the surface integrity include bulk
modification of the biodegradable medical device including,
but not limited to, alloying, forming, hot forming, Squeeze
casting, deep rolling, equal channel angular pressing, and
heat treatments. In forming processes—including, but not
limited to, rolling, pressing, extruding, and drawing—the
ability the impart a favorable surface integrity can be limited
by an implant's geometry. Complex implant geometries can
be required to treat some bone fracture and may not always be
capable of being processed by traditional forming and casting
operations.
Accordingly, there is a need for biodegradable medical
devices having appropriate stiffness and mechanical strength
to overcome challenges associated with other medical
devices, for instance, secondary Surgical intervention and
stress shielding. There is also a need for biodegradable medi
cal devices having an adjustable rate of degradation, and
methods of making the same. The compositions and methods
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eters on Surface microhardness.

25

DETAILED DESCRIPTION
30

35

SUMMARY

40

45

Biodegradable Implant Material
Medical devices disclosed herein can comprise a biode
gradable material (such as an alloy) that comprises a biode
gradable implant material and an alloying element. In one
embodiment, the biodegradable implant material is chosen
from any material capable of use in a medical device. In
another embodiment, the biodegradable implant material is
biocompatible. In another embodiment, the biodegradable
implant material is non-toxic. In yet another embodiment, the
biodegradable implant material is non-carcinogenic. In still
another embodiment, the biodegradable implant material is
non-mutagenic. In still yet another embodiment, the biode
gradable implant material has a modulus of elasticity similar
to the modulus of elasticity of bone. In a further embodiment,
the biodegradable implant material is lightweight and has a

density from 1.6 g/cm to 1.8 g/cm. In another embodiment,
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the biodegradable implant material is strong Such that it has a
tensile strength from 100 MPa to 500 MPa.
In one embodiment, the biodegradable implant material
includes a metal. In yet another embodiment, the biodegrad
able implant material includes magnesium. Magnesium (Mg)
is an essential element to metabolic activities of the human
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FIG. 1 depicts one embodiment of a microstructure of a
biodegradable Mg, CaO.8 alloy.
FIG. 2 depicts one embodiment of a setup that can be used
to surface treat a medical device by hybrid dry cutting/hydro
static burnishing.
FIG. 3 depicts exemplary adjustments to processing
parameters (e.g., contact pressure, feed, speed, strain rate)

FIG. 11 depicts exemplary effects of hydraulic burnishing
pressure on Subsurface microhardness.
FIG. 12 depicts exemplary effects of burnishing pass and
pattern on Subsurface microhardness.
FIG. 13 depicts exemplary effects of burnishing param
eters on residual stress.

disclosed herein address those and other needs.

Disclosed herein are biodegradable medical devices that
comprise biodegradable materials (e.g., magnesium-calcium
alloys) having at least one adjustable property chosen from
degradation rate, residual stress, hardness, grain size, Surface
roughness, density, compressive strength, tensile strength,
elastic limit, and elongation-at-rupture. Further, disclosed
herein is a method for producing a biodegradable medical
device by using a surface treatment (e.g., hybrid dry cutting/
hydrostatic burnishing or laser shock peening) that involves
varying processing parameters including, but not limited to,
contact pressure, feed, speed, and strain rate.
Additional advantages of the disclosure will be set forth in
part in the description that follows, and in part will be obvious
from the description, or can be learned by practice of the
aspects described below. The advantages described below
will be realized and attained by means of the elements and
combinations particularly pointed out in the appended
claims. It is to be understood that both the foregoing general
description and the following detailed description are exem
plary and explanatory only and are not restrictive.
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and the resulting changes in medical device properties (e.g.,
degradation rate, max residual stress, depth of max hardness,
hardness on top surface, Surface roughness, max hardness of
Subsurface, residual stress on top surface, and depth of max
residual stress).
FIG. 4 depicts one embodiment of the degradation of Sur
face treated biodegradable Mg, CaO.8 implants in simulated
body fluid at 50 hours.
FIG. 5 depicts one embodiment of the degradation of Sur
face treated biodegradable Mg, CaO.8 implants in simulated
body fluid at 100 hours.
FIG. 6 depicts one embodiment of the degradation of Sur
face treated biodegradable Mg, CaO.8 implants in simulated
body fluid at 150 hours.
FIG.7 depicts one embodiment of a setup that can be used
for eudiometry.
FIG. 8 depicts embodiments of surface profiles.
FIG.9 depicts exemplary effects of burnishing parameters
on Surface roughness.
FIG. 10 depicts exemplary effects of burnishing param

body and, for instance, an adult human may require an intake
of 300-400 mg of magnesium daily. The close modulus of
elasticity between magnesium (40 GPa) and bone (10-30
GPa) can minimize stress shielding. Magnesium can degrade
significantly in Saline media Such as human body environ
ment. Without being bound to theory, dissolution of magne
sium in chloride-containing media (including, but not limited
to, the human body) can happen through the following reac
tion:

Magnesium can react with water, which is plentiful in
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bodily fluids, and produce Mg" ions, hydroxide, and hydro

gen gas. In high pH (>11.5) environments, magnesium
hydroxide can form a stable protective layer on the surface of
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medical devices comprising magnesium. In lower pH (<11.5)
environments, magnesium hydroxide is unstable and can
facilitate degradation of the biodegradable material (such as a
magnesium-calcium alloy) in aqueous solution. In some
embodiments, the biodegradable implant material including
magnesium is present at the implant-bone interface. In some
embodiments, the local pH at implant-bone interface is 7.4. In
some embodiments, the local pH at the implant-bone inter
face is less than 7.4, due to, for instance, secondary acidosis
resulting from metabolic and resorptive processes after Sur
gery. Without being bound to theory, it is thought that the
magnesium hydroxide layer cannot cover an implant's Sur
face in lower pH environments. Therefore, the constant expo
Sure to high chloride-containing electrolyte of the physiologi
cal system can cause an accelerated degradation on a
biodegradable medical device comprising magnesium in

6
Biodegradable Medical Device
The biodegradable implant material and alloying element
can be alloyed in a biodegradable material, and the biode
gradable material can be incorporated into a biodegradable
medical device. In one embodiment, calcium is alloyed with
magnesium to form a biodegradable material comprising a
magnesium-calcium alloy for use in a biodegradable medical
device. In another embodiment, 0.8 wt % of calcium is
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ions. Magnesium facilitates the incorporation of calcium into

bone. Therefore, the simultaneous release of Mg" and Ca"
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present in the biodegradable material in an amount from 0.6
wt % to 1.2 wt.%. In yet another embodiment, the calcium is
present in the biodegradable material in an amount of 0.5 wt

%, or 3.0 wt %, where any of the stated values can form an
upper or lower endpoint of a range. In a specific example, the
calcium is present in the biodegradable material (e.g., mag
nesium-calcium alloy) in an amount of 0.8 wt %. Other alloy
ing elements include, but are not limited to, zinc, aluminum,
manganese, silver, gold, nickel, copper, silicon, lithium,
indium, gadolinium, cerium, neodymium, lanthanum,
yttrium, ytterbium, erbium, dysprosium, praseodymium, and
1O.

ions from biodegradable materials comprising magnesium
calcium alloys can benefit the bone healing process. Calcium
can produce hydroxy-apatite (HA) mineral as a degradation
product. Hydroxy-apatite with the formula Cao (PO)(OH),
is a naturally occurring form of calcium apatite and resembles
the chemical and mineral components of bone. In one
embodiment, hydroxy-apatite stimulates bone cells to attach
to the biodegradable medical device surface and promote
bone cell adhesion.

0.5 wt % to 3 wt %. In another embodiment, the calcium is

%, 0.6 wt %, 0.7 wt %, 0.8 wt %, 0.9 wt %, 1.0 wt %, 1.1 wt
%, 1.2 wt %, 1.3 wt %, 1.4 wt %, 1.5 wt %, 1.6 wt %, 1.7 wt
%, 1.8 wt %, 1.9 wt %, 2.0 wt %, 2.1 wt %, 2.2 wt %, 2.3 wit
%, 2.4 wt %, 2.5 wt %, 2.6 wt %, 2.7 wt %, 2.8 wt %, 2.9 wit

solved Mg" ions that can be absorbed or consumed by the
ing a magnesium-calcium alloy can produce dissolved Ca"

human body. Additionally, a biodegradable material compris

vivo.

Alloying Element
The biodegradable implant material can be alloyed with an
alloying element to adjust the degradation rate of the biode
gradable implant material. In one embodiment, the alloying
element is any element capable of alloying with the biode
gradable implant material to adjust the degradation rate of the
biodegradable implant material. In another embodiment, the
alloying element is biocompatible. In another embodiment,
the alloying element is non-toxic and has non-toxic degrada
tion by-products when alloyed with the biodegradable
implant material. In yet another embodiment, the alloying
element is non-carcinogenic and has non-carcinogenic deg
radation by-products when alloyed with the biodegradable
implant material. In still another embodiment, the alloying
element is non-mutagenic and has non-mutagenic degrada
tion by-products when alloyed with the biodegradable
implant material. In still yet another embodiment, the alloy
ing element has a density Such that the resultant biodegrad
able material has a similar density to bone.
In one embodiment, the alloying element includes calcium.
Calcium (Ca) is a component in human bone that can be
essential in chemical signaling with cells. In one embodi
ment, the calcium is present in an amount Sufficient to reduce
the rate of degradation of the biodegradable implant material.
In another embodiment, the calcium is present in a low
enough amount to prevent significant precipitation of an
intermetallic phase Such as MgCa on and within grain
boundaries. In another embodiment, the calcium is present at
an amount equivalent to its maximum solubility in the biode
gradable implant material at room temperature. In one
embodiment, the calcium is present in the biodegradable
material (e.g., magnesium-calcium alloy) in an amount from

alloyed with magnesium to form a biodegradable material
comprising a magnesium-calcium alloy (MgCaO.8) for use in
a biodegradable medical device. A biodegradable material
comprising a magnesium-calcium alloy can produce dis

55

60

65

Additional components can also be incorporated into the
biodegradable material including, but not limited to, zinc,
aluminum, manganese, silver, gold, nickel, copper, silicon,
lithium, indium, gadolinium, cerium, neodymium, lantha
num, yttrium, ytterbium, erbium, dysprosium, praseody
mium, and iron.
The biodegradable material comprising the biodegradable
implant material and the alloying element can be incorpo
rated into a variety of medical devices. In one embodiment,
the biodegradable medical device is an orthopedic implant. In
another embodiment, the biodegradable medical device is a
prosthesis. In yet another embodiment, the biodegradable
medical device is for use in a cardiovascular application. In
still another embodiment, the biodegradable medical device
is a drug-delivery device. In a further embodiment, the bio
degradable medical device is a diagnostic device. Exemplary
biodegradable medical devices include, but are not limited to,
orthopedic pins, orthopedic screws, orthopedic plates,
replacement joints, bone prostheses, cements, intraosseous
devices, pacemakers, drug-supply devices, neuromuscular
sensors and stimulators, replacement tendons, Subperiosteal
implants, ligation clips, electrodes, artificial arteriovenous
fistulae, heart valves, Vascular grafts, internal drug-delivery
catheters, Ventricular-assist devices, laparoscopes, arthro
Scopes, draining systems, dental cements, dental filling mate
rials, skin Staples, intravascular catheters, ulcer tissue dress
ing, burn tissue dressing, granulation tissue dressing,
intraintestinal devices, endotracheal tubes, bronchoscopes,
dental prostheses, orthodontic devices, intrauterine devices,
and healing devices.
The biodegradable medical device can be configured for
use in different patients. In one embodiment, the biodegrad
able medical device is configured for use in applications for
adult humans. In another embodiment, the biodegradable
medical device is configured for use in pediatric applications.
In yet another embodiment, the biodegradable medical device
is configured for use in veterinary applications. In some
embodiments, the biodegradable medical device is config
ured to match the healing rate of a patient. The healing rate of
a bone fracture depends on a variety of factors including, but
not limited to, physiological conditions, age, weight, height,

US 9,084,843 B2
7
gender, ethnicity, and overall health. Thus, the healing rate
and configuration of the biodegradable medical device can
differ from one application to the other.
Surface Treatment

The biodegradable medical device can be surface treated to
further adjust the properties and the biological response of the
biodegradable medical device. The biodegradable medical
device properties that can be modified by surface treatment
include, but are not limited to, residual stress, hardness, grain
size, Surface roughness, compressive strength, tensile
strength, elastic limit, elongation-at-rupture, and degradation
rate as well as their profiles below the surface. Profiles below
the surface include, but are not limited to, the depth that the
previously mentioned properties extend at well as the depth of

10

their maximums and minimums.

15

The biodegradable medical device properties can be
adjusted by tuning the processing conditions used in the Sur
face treatment including, but not limited to, contact pressure,
feed, speed, strain rate, laser power, ball size, number of
passes, pattern, temperature, dent spacing, and focal length.
The Surface treatment can be any surface treatment that can
adjust the Surface and near Surface properties of the biode
gradable medical device. Exemplary Surface treatments
include, but are not limited to, laser shock peening, shot
peening, dry cutting, hydrostatic burnishing, or combinations

25

thereof.

In one embodiment, the biodegradable medical device is
surface treated by hybrid dry cutting/hydrostatic burnishing
to adjust the degradation rate of the biodegradable medical
device. In some embodiments, hybrid dry cutting/hydrostatic
burnishing is tuned during the biodegradable medical device
manufacturing stage to adjust surface integrity in such a way
that the resultant degradation rate approximates the healing
rate for a certain orthopedic application. FIG. 2 depicts one
embodiment of a setup that can be used to Surface treat a
biodegradable medical device by hybrid dry cutting/hydro
static burnishing. FIG. 8 depicts embodiments of various
Surface profiles that can be achieved using the Surface treat
ments disclosed herein. In the hybrid dry cutting/hydrostatic
burnishing technique, material cutting and forming can be
performed on the same computer numerical controlled
(CNC) machine sequentially or simultaneously; thus, the ini
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surface as well as a microhardness of at least 50 HV is

required. Thus according to FIG. 3, a biodegradable medical
device that is surface treated by burnishing at a contact pres
35

sure of 2.1 GPa, feed of 0.1 mm, and a strain rate of 10's

will provide the desired surface integrity and corrosion rate.
In one embodiment, the Surface treatment includes any
treatment that can adjust the degradation rate of a biodegrad
able medical device. In another embodiment, the surface
40

tial investment on hardware can be lower than other tech

niques.
Material cutting includes removing material on the Surface
of a biodegradable medical device by sharp cutting tools in
incremental layers either with or without cutting fluids. In
FIG. 2 which depicts one embodiment of a setup that can be
used to surface treat a medical device by hybrid dry cutting/
hydrostatic burnishing the cutting tool is equipped with
nine diamond cutting inserts that spin at very high speeds. The
biodegradable medical device is firmly fixed using the three
jaw chuck. As the tool is lowered, it engages the workpiece
and begins removing a layer of material. The depth of this
engagement is known as the depth-of-cut. During the cutting
process, part of the Surface on a biodegradable medical device
is removed via chip formation while the freshly formed sur
face is simultaneously plowed over by the cutting tool. With
properly chosen cutting conditions, the newly plowed Surface
can have a surface integrity that changes the mechanical
properties and biological response of a biodegradable medi
cal device. Tunable cutting parameters depend on the alloy
being machined and include, but are not limited to, spinning
speed of the tool, horizontal speed of the tool (feed), depth
of-cut, cutting tool material and its geometry.
Cutting processes can generate considerable amounts of
heat. Thus, cutting fluids can be used. Still, their widespread

8
use is controversial because of the ecological issues that arise.
In the case where no cutting fluids are used, the process is
known as dry cutting. Using diamond cutting inserts on, for
instance, magnesium alloys (which are comparatively soft),
can make eco-friendly, dry cutting feasible.
After dry cutting, material forming via burnishing can
shape the biodegradable medical device into final form with
out removing material. In the embodiment shown in FIG. 2,
the tooling can be changed in the CNC machine so that
hydrostatic burnishing tool can be installed. The surface of
the biodegradable medical device can then be burnished using
predetermined burnishing process parameters to provide the
desired surface integrity. Hydrostatic burnishing includes a
Smooth free-rolling ceramic ball that is pressed against and
rolled along the Surface of the work piece using a pressurized
hydraulic cushion. As the result, it deforms the work piece
Surface into a state of compression. This process is character
ized by the combination of, for instance, the following three
physical effects: (i) deep and stable compressive residual
stresses, (ii) work hardening and increase in microhardness,
and (iii) burnishing or decreasing Surface roughness. The
tunable process parameters in burnishing that can adjust
properties of the biodegradable medical device include, but
are not limited to, contact pressure, feed, speed of movement
in horizontal plane, overlap/feed, tool geometry (ceramic ball
diameter), burnishing pattern, and temperature.
In one embodiment, the desired Surface integrity from a
practitioner is to have a smooth Surface finish and a degrada
tion rate of 1 mm/yr. To achieve those properties, a maximum
residual stress of -150 MPa approximately 0.5 mm from the
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treatment includes any treatment that can adjust the degrada
tion rate of the biodegradable medical device to match that of
the healing rate of a bone fracture such that a patient heals at
the same rate that the patient’s biodegradable medical device
degrades. In some embodiments, the Surface treatment
induces compressive residual stress into at least a portion of
the biodegradable medical device (e.g., on or below the sur
face of the biodegradable medical device or a portion
thereof). In some embodiments, the Surface treatment induces
porous Surface microstructure in at least a portion of the
biodegradable medical device.
In another embodiment, the surface treatment alters the

topography of at least a portion of the biodegradable medical
device. In another embodiment, the Surface treatment pro
duces refined grains in at least a portion of the biodegradable
55
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medical device. In another embodiment, the surface treat

ment produces a better Surface finishin at least a portion of the
biodegradable medical device. In yet another embodiment,
the Surface treatment creates a geometric benefit in at least a
portion of the biodegradable medical device that assists in the
healing process. In one embodiment, the Surface treatment
provides a porous structure in at least a portion of the biode
gradable medical device that is favorable for cell adhesion
and growth between the biodegradable medical device and
bone. Exemplary input variables that can adjust the biode
gradable medical device properties include, but are not lim
ited to, contact pressure, feed, speed, and strain rate, dis
cussed in more detail below.
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Ifan obese patient carried more stress along the medial side
of the femur, a biodegradable medical device on the medial
side of the femur can be processed at a higher contact pressure

Contact Pressure

The contact pressure used in the Surface treatment can be
adjusted. For instance, the contact pressure can be adjusted to
from 1 gigapascal to 5 gigapascals (e.g., from 1.3 gigapascals
to 2.1 gigapascals, from 2.1 gigapascals to 4.7 gigapascals,
from 2.9 gigapascals to 4.7 gigapascals). FIG. 3 depicts
examples of how adjusting the contact pressure can change
the biodegradable medical device properties (e.g., degrada
tion rate, maximum residual stress, depth of maximum hard
ness, hardness on top surface, Surface roughness, maximum
hardness of Subsurface, residual stress on top Surface, and
depth of maximum residual stress). The contact pressure can
be adjusted by increasing or decreasing desired force or
power. Adjustments to the contact pressure can be changed
using a computer program that controls the desired Surface
treatment process. The contact pressure can be adjusted Such
that a desired surface integrity is achieved to accommodate a
patient’s conditions. In one embodiment, a practitioner would
conduct a bone density (BMD) scan to indicate if a patient has
osteoporosis or is a fracture risk. Depending on the severity
indicated on that bone density Scan, a practitioner would
request a biodegradable medical device suitable for the
patient’s needs. Biodegradable medical devices processed
with a high contact pressure are desirable for patients with
low bone density because they may not produce fast, new
bone growth and thus may require a slow biodegradable

so that the later residual stress and microhardness increase the

fracture toughness and fatigue life of the device. In yet
another embodiment, the location and orientation of the frac

ture and later fracture treatment may require one or more
surfaces of the biodegradable medical device to be processed
at one or more contact pressures such the biodegradable
10
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Feed
The feed is the distance of relative lateral movement

25

medical device.

According to the National Osteoporosis Foundation, the
higher risk groups for low bone density include the elderly,
menopausal and post-menopausal women, patients with a
family history of low bone density, patients with a low body
weight or eating disorders, and patients who have had a frac
ture as an adult. In another embodiment, the practitioner
would decide based on patient factors including, but not lim
ited to, age, weight, medical history, gender, medical condi
tion, and health, that the patient needs a biodegradable medi
cal device that degrades at a rate based on a preset scale from
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device that had a faster corrosion rate. A faster corrosion rate

is accomplished by using lower contact pressures. In yet
another embodiment, the location and orientation of the frac

ture and Subsequent fracture treatment may require one or
more surfaces of the biodegradable medical device to be
processed at one or more contact pressures such the biode
gradable medical device has unique properties at one or more

45

locations on the Surface.

One or more unique properties include, but are not limited
to, residual stress, microhardness, corrosion rate, fatigue life,
and fracture toughness. An example of the previously men
tioned embodiment is a patient who is obese and suffered a
bone fracture. The obese patient may distribute stresses dif
ferently in their bones and consequently affect the healing
process. A biodegradable medical device in the form of a plate
aligned along the femur of an obese patient may cause a
higher bending or torsional stress as opposed to pure axial
stress. In Such a case, a practitioner may require a biodegrad
able medical device that is stronger and/or weaker on at least
one or more portions of one or more surfaces to control the
device's degradation in a way that accounted for the stress
distribution of the obese patient. This can be accomplished by
changing the contact pressure used during the Surface treat
ment on at least one or more portions of one or more surfaces
of the biodegradable medical device that best suited the
patient’s needs.

between the tool and a biodegradable medical device. In the
case of burnishing, the feed is the center-to-center distance
between Successive burnishing tracks. In laser shock peening,
the feed is the center-to-center spacing between Successive
peens. The feed used in the Surface treatment can be adjusted.
For instance, the feed can be adjusted to from 0.06 millime
ters to 1.2 millimeters (e.g., from 0.06 millimeters to 0.4
millimeters, from 0.4 millimeters to 1.2 millimeters). FIG. 3
depicts examples of how adjusting the feed can change the
biodegradable medical device properties (e.g., degradation
rate, max residual stress, depth of max hardness, hardness on
top Surface, Surface roughness, max hardness of Subsurface,
residual stress on top surface, and depth of max residual
stress).
The feed can be adjusted by changing a computer program
that controls the movements of the tool. The suitable feed for
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1 to 5, where 1 indicates a slow corrosion rate, 3 indicates a

moderate corrosion rate, and 5 indicates a rapid corrosion
rate. In another embodiment, a practitioner who is treating a
child for a fracture would request a biodegradable medical

medical device corrodes at one or more locations in one or

more desired directions. Degrading at different corrosion
rates in one or more directions is accomplished by establish
ing a gradient of the previously mentioned Surface integrity
properties. A gradient can be achieved in a specific location
by varying the contact pressure while moving either the bio
degradable medical device or tooling.

50

a patient depends on factors including, but not limited to, the
desired Surface roughness and corrosion rate. For a young
patient, a feed of 1.2 mm using a high Strain-rate process or
0.06 mm to 0.2 mm using a low strain-rate process can be
desirable because young patients produce new bone faster
than adults and would thus need a fast-degrading implant.
However, elderly patients and those who show signs of low
bone density may require a biodegradable medical device that
had been processed at a feed of 0.4mm and a high Strain-rate
so that the implant would degrade as slowly as possible.
Depending on the type and location of fracture as well as the
general health of the patient, the practitioner may desire an
implant with a rough Surface. Adjusting the feed produces
Surfaces with a different roughness that can promote bone
implant adhesion and ingrowth. Also, the location and orien
tation of the fracture and later fracture treatment may require
the surface of the implant to be processed at a specific feed
Such the biodegradable medical device corrodes at a specific
location or in a desired direction.
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Speed
The speed refers to the velocity of the tool used in process
ing the biodegradable medical device. For example, the speed
of the burnishing tool. The speed used in the surface treatment
can be adjusted. For instance, the speed can be adjusted from
50 millimeters perminute to 900 millimeters perminute (e.g.,
from 100 millimeters per minute to 800 millimeters per
minute, from 300 millimeters per minute to 600 millimeters
per minute). FIG. 3 depicts examples of how adjusting the
speed can change the biodegradable medical device proper
ties (e.g., degradation rate, max residual stress, depth of max
hardness, hardness on top Surface, Surface roughness, max
hardness of Subsurface, residual stress on top surface, and
depth of max residual stress).
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The speed can be adjusted by changing a computer pro
gram that controls the movements of the tool. The speed can
adjust the corrosion rate of the biodegradable medical device.
In one embodiment, a practitioner may require a device pro
cessed at high speeds for young and/or patients with adequate
bone density. At high speeds, the corrosion rate is faster,
which is ideal for patients who generate new bone more
rapidly. At low speeds, the corrosion rate is slower, which is
ideal for patients who do not generate new bone rapidly. The
desired healing profile is what a practitioner would provide a
manufacturing engineer. The engineer knowing the correla
tions between various process parameters, Surface integrity
characteristics, and degradation rates decides which param
eter to adjust and how much so that after implantation, the
healing rate and degradation rate match. Also, the location

10
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and orientation of the fracture and later fracture treatment

may require the Surface of the implant to be processed at one
or more speeds such the biodegradable medical device cor
rodes differently at one or more locations or in one or more
desired directions.
Strain Rate
The strain rate describes the rate of material deformation

and is often determined by the manufacturing process. The
strain rate when processing a biodegradable medical device
and consequent Surface integrity properties can be adjusted
by using one or more manufacturing processes. For example,
the strain rates for burnishing and laser shock peening pro

cesses are on the order of 10's and 10's", respectively.
Therefore, the strain rate can be adjusted to from 10s to 10°
s' (e.g., from 10°s' to 10s', from 10s to 10's'). FIG.
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3 depicts examples of how adjusting the strain rate can change
the biodegradable medical device properties (e.g., degrada
tion rate, max residual stress, depth of max hardness, hard
ness on top Surface, Surface roughness, max hardness of Sub
Surface, residual stress on top surface, and depth of max
residual stress). Based on a patient’s age, weight, and gender,
a practitioner would select a device processed at a specific
strain rate that caused said device to initiate and propagate
degradation at a predetermined rate that Suitably matches the
needs of the patient. Patients with known bone diseases or low
bone density, such as elderly women, would require an
implant processed at a high Strain rate, which would cause a
slow corrosion rate. Patients with healthy bone would need an
implant processed at a low strain rate, which would cause a
faster corrosion rate. Patients who are overweight or suffer
from a bone disease may distribute stress differently with
their body. Therefore, said patients may require an implant
processed at one or more locations on the biodegradable
medical device, which can either delay the onset of corrosion
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or accelerate the onset of corrosion to match their needs in
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terms of healing and stress distribution.
Adjustable Properties
Each combination of surface treatment variables leaves

behind unique properties that define the Surface integrity on
and near the surface of a biodegradable medical device. The
properties of the biodegradable medical device can be
adjusted in a variety of ways. In some embodiments, the
amount of the alloying element can be adjusted to affect the
properties of the biodegradable medical device. In some
embodiments, the surface treatment can be adjusted to affect
the properties of the biodegradable medical device. Exem
plary properties that can be adjusted by the amount of alloy
ing element and/or Surface treatment include, but are not
limited to, hardness, grain size, Surface roughness, density,
residual stress, compressive strength, tensile strength, elastic
limit?elastic modulus, elongation-at-rupture, fracture tough
ness, fatigue life, and degradation rate. In some embodiments,
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the alloying element is calcium and the amount of calcium is
adjusted to affect the properties of a magnesium-calcium
alloy. In some embodiments, the Surface treatment (e.g.,
hybrid dry cutting/hydrostatic burnishing) is adjusted to
affect the properties of a biodegradable medical device com
prising a biodegradable material comprising a magnesium
calcium alloy. FIG.3 depicts examples of how adjusting the
processing parameters of the Surface treatment (e.g., contact
pressure, feed, speed, and strain rate) can change the biode
gradable medical device properties (e.g., degradation rate,
max residual stress, depth of max hardness, hardness on top
Surface, Surface roughness, max hardness of Subsurface,
residual stress on top surface, and depth of max residual
stress).
Degradation Rate
Degradation rate is a measure of how quickly the biode
gradable medical device degrades in the human body. The
degradation rate of the biodegradable medical device can be
impacted by the degradation resistance of the biodegradable
material (e.g., a biodegradable material comprising a magne
sium-calcium alloy). For example, the degradation resistance
of a biodegradable material comprising a magnesium-cal
cium alloy decreases with increasing amount of calcium,
which is related to Mg-Caprecipitates on grain boundaries
and within grains. In one embodiment, a biodegradable mate
rial comprising a magnesium-calcium alloy with 0.8 wt %
calcium can be used to obtain an optimum combination of
mechanical strength, plasticity, ductility, and degradation rate
by alloying. In one embodiment, the 0.8 wt % of calcium
concentration is the maximum solubility of calcium in a mag
nesium lattice at room temperature. FIG. 1 shows an embodi
ment of the microstructure of a Mg. CaO.8 alloy. When
calcium is alloyed in an amount of 0.8 wt %, MgCa can
precipitate on grain boundaries and inside the grains can
promote more moderate and uniform rather than fast and
localized degradation. In another embodiment, the calcium
content is less than 0.8 wt %, which can yield less ductility
and mechanical strength. In yet another embodiment, the
calcium content is greater than 0.8 wt %, which can cause
MgCa precipitation and ultimately decreased degradation
resistance due to feasibility of galvanic degradation.
During magnesium dissolution of a magnesium-contain
ing biodegradable medical device, hydrogen gas is produced
at the same rate that magnesium dissolves. As such, eudiom
etry of hydrogen can be used to determine long term degra
dation behavior of Mg CaO.8 implants in simulated body
fluid. FIG. 7 depicts one embodiment of a setup that can be
used for eudiometry. FIGS. 4-6 depict exemplary data of the
degradation of Mg CaO.8 implants processed by dry cutting
and hybrid dry cutting/hydrostatic burnishing under different
process parameters. The added burnishing treatment after dry
cutting can decrease the degradation rate of the biodegradable
medical device. Also, increasing the contact pressure can
further decrease the corrosion rate. These results shown in
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FIGS. 3-6 confirm hybrid dry cutting/hydrostatic burnishing
is one embodiment of a manufacturing process that can alter
the corrosion rate of a biodegradable medical device.
In one embodiment, the degradation rate of the biodegrad
able medical device is adjusted by alloying. In another
embodiment, the degradation rate of the biodegradable medi
cal device is adjusted by surface treatment of the biodegrad
able medical device. In yet another embodiment, the degra
dation rate of the biodegradable medical device is adjusted by
Surface treatment and alloying. In another embodiment, the
degradation rate of the biodegradable medical device is
adjusted to match that of the healing rate of bone such that a
patient heals at the same rate that the patient’s biodegradable
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medical device degrades. The healing rate of bone in a patient
can be approximated by any method known in the art. For
instance, the healing rate of bone in a patient can be found in
textbook references that are known to those of ordinary skill
in the art. For example, the degradation rate can be adjusted to
from 0.001 millimeter per year to 20 millimeters per year
(e.g., from 0.01 millimeters per year to 10 millimeters per
year, from 0.1 millimeters per year to 1 millimeters per year).
Two methods to measure degradation rate include: (1)
immersion testand (2) potentiodynamic test. In an immersion
test, the evolved hydrogen is collected over time and then
using the Stoichiometry of the degradation reaction, degrada
tion rate is calculated. In potentiodynamic test, corrosion
current density is measured using electrochemistry principals
and then the current density is converted to degradation rate
using Faraday's law.
Density
Density is a measure of a materials mass per unit volume.
In one embodiment, the density of the biodegradable material

5

micrometers or less, 6 micrometers or less, 4 micrometers or

10

15

in the biodegradable medical device is from 1.5 g/cm to 3.5
g/cm. In another embodiment, the density of the biodegrad
able material in the biodegradable medical device is from 1.7
g/cm to 2.0 g/cm. The bulk density of a biodegradable
medical device can be altered by changing the compositional
elements that make up the alloy.

25

Residual Stress
Residual stresses are those stresses that remain on or near

the surface of a biodegradable medical device after a surface
treatment. In some embodiments, the Surface treatment

induces residual stress into at least a portion of the biodegrad
able medical device (e.g., on or below the surface of the
biodegradable medical device or a portion thereof). For
example, the residual stress can be from -170 megapascals to
-20 megapascals (e.g., from -160 megapascals to -50 mega
pascals, from -150 megapascals to -100 megapascals). The
residual stress can have a maximum depth in the biodegrad
able medical device. For example, the maximum residual
stress depth can be from 5 micrometers to 600 micrometers
(e.g., from 10 micrometers to 500 micrometers, from 20

30

micrometers to 400 micrometers, from 50 micrometers to 300

40

micrometers, from 150 micrometers to 250 micrometers).
One method to measure residual stress is by X-ray diffraction.
Changing the process parameters of a surface treatment
affects the resulting magnitude and depth of the residual
stress on and below the Surface. For example, increasing the
contact pressure causes the depth of the maximum residual
stress to increase. FIGS. 3 and 13 depict exemplary effects of
various burnishing parameters on residual stress.

35

45

50

55

60

micrometers to 600 micrometers, from 300 micrometers to

500 micrometers). ASTM E112 standard is used to determine
average grain size. In most metals and their alloys, a smaller
grain size can increase the strength of a material.

Elastic limit (i.e., elastic modulus) is a measure of plastic
ity. In one embodiment, the elastic limit of the biodegradable
medical device is from 10 gigapascals (GPa) to 80 GPa. In
another embodiment, the elastic limit of the biodegradable
material (e.g., a biodegradable material comprising a magne
sium-calcium alloy) is from 30 GPa to 60 GPa. In a further
embodiment, the elastic limit of the biodegradable material
(e.g., a biodegradable material comprising a magnesium-cal
cium alloy) is from 40 GPa to 50 GPa. The content of calcium
as an alloying element affects the 0.2% elastic limit, as shown
in FIG. 1. In embodiments having low calcium content, the
elastic limit is 80 MPa lower than tensile strength. This can
indicate relatively high plasticity. With increasing amount of
calcium, for instance amounts of at least 2.0 wt %, plasticity
decreases and without significantly effecting tensile strength.
ASTM E8 standard is used to determine elastic limit of metal
lic materials.

atomic orientations are different.

Mechanical properties can be adjusted as the size of the
grains is changed. Alloy composition and processing (either
bulk or on the surface) can be adjusted to achieve the desired
grain size. For example, the grain size can be adjusted to from
100 micrometers to 700 micrometers (e.g., from 200

less). The Surface roughness can be measured using either a
laser or a mechanically contacting profilometer. The Surface
roughness largely depends on the nature of deformation dur
ing a Surface treatment. Process parameters such as contact
pressure, feed and speed can drastically influence the result
ing roughness profile. For example, burnishing typically cre
ates a roughness on the order of 100's of nanometers, while
laser shock peening is more on the order of 10's of microme
ters. A rough profile may be more desirable for bone-in
growth applications while a Smooth profile may be preferred
in arterial flow applications. FIGS. 3 and 9 depict exemplary
effects of burnishing parameters on Surface roughness.
Tensile/Compressive Strength
Strength is a measure of the maximum stress that a material
can withstand while being stretched (tension) or squeezed
(compression) without failing. Alloying magnesium with cal
cium increases the tensile strength of the resultant biodegrad
able medical device. In one embodiment, magnesium is
alloyed with low amounts of calcium to increase the tensile
strength of the biodegradable medical device. In another
embodiment, magnesium is alloyed with calcium in an
amount less than or equal to 4.0 wt % to increase the tensile
strength of the biodegradable medical device to an amount of
less than or equal to 240 MPa. ASTM E8 standard is used to
determine tensile strength of metallic materials.
Elastic Limit or Elastic Modulus

Grain Size

Metals, except in a few instances, are crystalline in nature
and, except for single crystals, contain internal boundaries
known as grain boundaries. When a new grain is nucleated
during processing (as in Solidification or annealing after cold
working, for example), the atoms within each growing grain
are lined up in a specific pattern that depends upon the crystal
structure of the metal or alloy. With growth, each grain will
eventually impinge on others and forman interface where the

14
Surface Roughness
Surface roughness is a measure of the texture of the Sur
face. Surface roughness can be adjusted to change the biode
gradable medical device properties. For example, the Surface
roughness can be adjusted to 10 micrometers or less (e.g., 8

65

Elongation-at-Rupture
Elongation-at-rupture is a measure of ductility. The
amount of the alloying element, such as calcium, can also
affect the elongation-at-rupture and ductility as well. There is
a continuous decrease in elongation-at-rupture and ductility
above 1.0 wt % Ca. Considerable precipitation of brittle
MgCa intermetallic phase on grain boundaries and inside
grains is responsible for this decline inductility above 1.0 wt
% Ca. ASTM E8 standard is used to determine elongation
at-rupture of metallic materials.
Hardness

Hardness can be adjusted in the biodegradable medical
device. In some embodiments, the Surface treatment adjusts
the hardness of at least a portion of the biodegradable medical
device (e.g., on or below the surface of the biodegradable
medical device or a portion thereof). For example, the hard
ness can be of from 40HV to 140HV (e.g., from 45 HV to 125
HV, from 50 HV to 100 HV, from 55 HV to 75 HV). The
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hardness can have a maximum depth in the biodegradable
medical device. For example, the maximum hardness depth
can be from 5 micrometers to 175 micrometers (e.g., from 10

16
meters per minute, 0.05 millimeters per revolution, and 0.2
millimeters, respectively. Burnishing was performed using an
Ecoroll HG13 tool. It uses a ceramic ball made of silicon
nitride that is 12.7 millimeters in diameter and has 10 milli

micrometers to 150 micrometers, from 15 micrometers to 125
micrometers, from 25 micrometers to 100 micrometers, from

40 micrometers to 75 micrometers). ASTM E92-82 and

E384-06 standards are used to measure hardness. FIGS. 3 and

10-12 depict embodiments of the effects of various burnish
ing parameters on microhardness.
Other than in the examples, or where otherwise noted, all
numbers expressing quantities of ingredients, reaction con
ditions, and so forth used in the specification and claims are to
be understood as being modified in all instances by the term
"about.” Accordingly, unless indicated to the contrary, the
numerical parameters set forth in the specification and
attached claims are approximations that may vary depending
upon the desired properties sought to be obtained by the
present disclosure. At the very least, and not as an attempt to
limit the application of the doctrine of equivalents to the scope
of the claims, each numerical parameter should be construed
in light of the number of significant digits and ordinary round
ing approaches.
Notwithstanding that the numerical ranges and parameters
setting forth the broad scope of the invention are approxima
tions, unless otherwise indicated the numerical values set

forth in the examples are reported as precisely as possible.
Any numeric value, however, inherently contains certain
errors necessarily resulting from the standard deviation found
in their respective testing methods. Finally, the various titles
and section headers used throughout the specification are
presented merely for the convenience of the reader and are not

10

15

forces were 10g. The residual stress was measured using a

4-axis Bruker D8 XRD by applying 35 milli-Amps current
and 40 kilo-Volts using a copper source. The wavelength was
0.1542 nanometers. The collimator was 0.8 millimeters in

diameter. Assuming plane stress conditions, residual stresses

were calculated based sin p method at a 20–118.48°.

25
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intended to limit the disclosure. The disclosure herein is not

limited to specific methods or reagents. Further, the terminol
ogy used herein is for the purpose of describing particular
aspects only and is not intended to be limiting.
By way of non-limiting illustration, examples of certain
embodiments of the present disclosure are given below.
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Example 1
Adjusting Degradation Rate of Mg CaO.8 Samples
Using Hybrid Dry Cutting/Hydrostatic Burnishing
FIG. 2 shows an exemplary hybrid dry-cutting/hydrostatic
burnishing setup. In hybrid technique material cutting and
material forming are combined and are performed on same
Cincinnati Arrow 500 CNC milling machine sequentially or
simultaneously. Material cutting is removing material from
the workpiece by sharp cutting tools until the final shape of
the device is attained. Material forming is shaping the work
piece into final form without material removal.
Calcium (Ca) was alloyed with magnesium (Mg) to form a
binary Mg Caalloy. Mgalloyed with 0.8 weight percent Ca
(Mg CaO.8) was prepared using pure Mg of ASTM grade
9980A and Mg-30% Ca master alloy. The pure Mg was
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1. A method of making a non-peened biodegradable medi
cal device having an adjustable degradation rate, comprising:
providing a biodegradable material comprising a biode
gradable implant material and an alloying element,
wherein the biodegradable implant material comprises
magnesium and the alloying element comprises calcium
in an amount of 0.8 percent by weight; and
Subjecting the biodegradable material to a surface treat
ment having an adjustable processing parameter to
adjust a property of the material;
wherein the adjustable processing parameters comprise
contact pressure, feed, speed, and strain rate;
wherein the contact pressure is adjusted to between 1 giga
pascal and 5 gigapascals, the feed is adjusted to between
0.06 millimeters to 1.2 millimeters, the speed is adjusted
to from 50 millimeters per minute to 900 millimeters per

minute, and the strain rate is adjusted to from 10s to
109s;

wherein the adjustment of the contact pressure, feed,
speed, and strain rate are adjusted to make a biodegrad
able medical device; and

melted down at 650° C. Next, the melt was heated to 710°C.

and Mg-30% Ca was added until the target composition
(Mg CaO.8) was obtained. After the alloy settled for /2 hour,
it was cast into ingots. The ingots were dry turned to 38
millimeter diameter round bars and sectioned with a SiO,
abrasive cutting wheel into 12.7 millimeter thick samples.
The face of each sample was machined by polycrystalline
diamond (PCD) insets utilizing the set-up shown in FIG. 2.
The surface cutting speed, feed, and depth-of-cut were 2400

The resultant surface integrity from hybrid dry cutting/
hydrostatic burnishing with the previously mentioned pro
cess parameters are presented below. The effect on the deg
radation rate was measured by an immersion test. In an
immersion test, the evolved hydrogen is collected over time
and then using the Stoichiometry of the degradation reaction,
degradation rate is calculated. The corresponding degrada
tion rates are provided in FIGS. 4-6. The added burnishing
treatment after dry cutting proved to decrease the degradation
rate of the biodegradable medical device. Also, increasing the
hydraulic pressure proved to decrease the corrosion rate fur
ther.
What is claimed is:

EXAMPLES

Treatment

meters of free stroke to accommodate for elevation changes.
The ceramic ball sits on a pressurized hydro cushion via a
high pressure hydraulic unit. This avoids the contact between
ball and spherical housing and guarantees free rolling along
the sample surface. The hydraulic unit is capable of hydraulic
pressures up to 40 megapascals. The power carrying fluid is
anti-wear, dual purpose Aries 15 oil functioning as both cool
ant and lubricant. Samples were burnished at hydraulic pres
sures of 2, 4, 6, 8, and 10 megapascals. Feeds varied from 0.04
to 0.2 millimeters. Speed varied from 50 to 890 millimeters
per minute.
The Surface roughness was measured using a Veeco Dek
Tak IIA Profilometer. Microhardness was measured using a
Buehler Hardness Tester with a Knoop indenter. The applied
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wherein the biodegradable medical device has a degrada
tion rate of from 0.001 millimeters per year to 20 milli
meters per year in an environment having a pH of 7.5 or
less, a maximum residual stress on or below the Surface

of from -170 megapascals to -20 megapascals, a maxi
mum hardness on or below the surface of from 40 HV to
65

140 HV, a grain size of from 100 micrometers to 700
micrometers, and a Surface roughness of from 0.1
micrometers to 10 micrometers.
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2. The method according to claim 1, wherein the strain rate

18

is adjusted to from 10s to 10s.

3. The method according to claim 1, wherein the contact
pressure is adjusted to from 1.3 gigapascals to 4.7 gigapas
cals.

4. The method according to claim 1, wherein the feed is
adjusted to from 0.4 millimeters to 1.2 millimeters.
5. The method according to claim 1, wherein the speed is
adjusted to from 300 millimeters per minute to 600 millime
ters per minute.
6. The method according to claim 1, wherein the surface
treatment is hybrid dry-cutting/hydrostatic burnishing.
k
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k
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